Tag: investment
-
Pharmas, BioPontis Alliance Partner on Translational Science
BioPontis Alliance, a hybrid investment fund and product development company in Raleigh, North Carolina, and global pharmaceutical company Pfizer Inc. agreed to collaborate on translational technology development supported by BioPontis. The companies announced the deal at the 2011 BIO International Convention in Washington, D.C. BioPontis establishes research alliances with academic-research institutes, where BioPontis searches for…
-
Genentech Gets Rights, Can Buy Out Biotech Research Program
The biotechnology company Forma Therapeutics in Cambridge, Massachusetts says it has an agreement with Genentech, a member of the Roche Group, granting Genentech exclusive rights to acquire one of Forma’s pre-clinical small molecule cancer research programs. The specific cancer target of the therapy under development is not disclosed. The agreement begins as a research collaboration…
-
North Africa, Middle East Entrepreneurial Programs Unveiled
Two new programs aimed at spurring innovation based on science and technology in North Africa, Middle East, and South Asia were unveiled at a kick-off meeting in Rabat, Morocco last week. The Civilian Research and Development Foundation (CRDF) in Arlington, Virginia manages the programs, with funding from the U.S. Department of State. One of new…
-
University Start Up Commercializes Feeding Tube Research
A start up company founded by a University of Utah medical researcher is developing a feeding tube for patients that reduces the risks and casualties from misplacement. The company, Veritract Inc. in Salt Lake City, was started by John Fang, clinical director of the university’s gastroenterology division. The privately held Veritract is developing what they…
-
Pfizer Adds Mass. Institutions to Translational Network
Pfizer Inc. in New York is adding eight Massachusetts research institutions to its network of translational research partnerships, called the Centers for Therapeutic Innovation. The company also says it will put the academic network’s headquarters in Boston, a $100 million investment over five years. Jose Carlos Gutierrez-Ramos, Pfizer’s vice-president for biotherapeutics research and development, says…
-
GE Technology Selected for First Gas/Wind/Solar Power Plant
GE says it will provide the basic technology for a power plant in Turkey that generates electricity with a combination of natural gas, wind, and solar power. The plant, to be built by MetCap Energy Investments, a Turkish development company, is expected to provide power for more than 600,000 homes when it goes online in…
-
U.S. Cosmetics Company Opens China R&D Center
Estée Lauder Companies Inc. in New York (ELC) is opening its Asia Innovation Center in Shanghai, China. The new center expands on the company’s research lab that opened in China in 2005. ELC has been doing business in China since 1993. The company says the center will help develop products tailored to the needs of…
-
Global Entrepreneurship Week to Recognize 50 New Start-Ups
Startup Open has launched its search for the 50 most promising new start-ups around the world as part of Global Entrepreneurship Week (GEW) 2011. Winners of the competition will be announced on 15 October 2011, with those companies then competing for the top honors. The competition, now in its second year, is open to entrepreneurs…
-
Solvay to Form Research Center at Korean Women’s University
Solvay, a chemical company in Brussels, Belgium, says it will locate its Korean research center on the campus of EWHA Women’s University in Seoul. The company’s investment in this venture will total EUR 16.8 million (USD 24.0 million). Solvay plans to invest EUR 13 million in a Research, Development and Technology (RDT) Centre at EWHA.…
-
$100 Million Investment Fund Set for Second-Stage Companies
Stage 2 Innovations, a new venture capital fund, and Automation Alley, a technology business group in Troy, Michigan, will identify companies for funding to support large-scale commercialization. The fund will support entrepreneurs with proven technologies that need financing to take their discoveries to the global market. Tom LaSorda (pictured right), former President and CEO of…